News Archive
The Board of Directors of Patterson Companies, Inc., today declared the quarterly cash dividend of $0.16 per share. The dividend will be payable on January 24, 2014, to shareholders of record on January 10, 2014.
A therapy that uses bone-marrow stem cells to promote heart repair did not significantly improve the primary outcome over a sham procedure among patients with congestive heart failure.
According to recently published Pharmaion report, "United States Hospital-acquired Infections Prevention Market Opportunities, 2010 - 2020", hospital-acquired infections prevention market in the United States is projected to grow at a CAGR of over 7% during 2015 - 2020.
Examining the treatment potential of cardiac cells derived from human pluripotent stem cells may lead to dramatically altering the care of cardiac disease and heart injuries, thanks to a grant from the National Institutes of Health.
› Verified 8 days ago